Evidence map›Paper›PMID 40678265›Full record

ArticleBioactive materials2025

Trimetallic Pt-Pd-Au alloy nanozymes for multimodal synergistic therapy to overcome deep-seated drug-resistant infections via ROS cascade.

Xiaojun He, Zijian Wang, Bangxun Mao, Hao Lin, Xuru Jin, Mengxuan Du, Binge Huang, Songlin Xin, Jinmiao Qu, Yun Feng

Abstract read
In one paragraph

Article in Bioactive materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaojun HeDepartment of Ophthalmology, Peking University First Hospital, Beijing, 100034, China.
Zijian WangSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Bangxun MaoDepartment of Ophthalmology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, China.
Hao LinDepartment of Ophthalmology, Peking University First Hospital, Beijing, 100034, China.
Xuru JinThe Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, 324000, China.
Mengxuan DuSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Binge HuangSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Songlin XinSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Jinmiao QuDepartment of Thyroid Surgery, National Key Clinical Specialty (General Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yun FengDepartment of Ophthalmology, Peking University First Hospital, Beijing, 100034, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To address the therapeutic challenges posed by deep-tissue drug-resistant bacterial infections, this study innovatively develops a multimodal synergistic therapeutic platform based on platinum-palladium-gold trimetallic alloy nanozymes (PPA). By overcoming the limitations of conventional photodynamic therapy (PDT) and electrodynamic therapy, such as restricted tissue penetration and operational complexity, this research integrates three advantageous strategies: photothermal therapy (PTT), chemodynamic therapy (CDT), and sonodynamic therapy (SDT) to construct a PPA system characterized by hierarchical nanostructures. The nanoplatform achieves efficient penetration through bacterial biofilm barriers attributed to its unique multi-branched architecture while exhibiting ultrasound (US)-laser dual-activated cascade catalytic effects and multimodal synergistic bactericidal mechanisms. Results demonstrate that PPA generates significant temperature gradients (with a photothermal conversion efficiency of 52.21 %) and bursts of reactive oxygen species (ROS) under combined near-infrared laser and US stimulation, effectively disrupting biofilm matrices and eradicating bacteria (with an inhibition ratio of 95 %). Integrated transcriptomic and proteomic analyses reveal that PPA operates through multiple mechanisms including the regulation of oxidative stress pathways, quorum sensing systems, and metabolic networks. Animal models illustrate the capability of PPA to accelerate deep infection wound healing while reducing inflammatory cytokine levels, alongside exhibiting excellent biocompatibility. This study transcends the limitations of traditional single-modal therapies by achieving precise synergy between nanozyme catalytic activity and physical field responses, establishing a novel "diagnosis-treatment-regulation" integrated paradigm for managing deep-seated tissue infections. Through engineered design and surface topological optimization, we successfully resolve the critical balance between nanozyme catalytic efficiency and biosafety, thereby laying the theoretical foundations for developing intelligent anti-infective materials.

Indexed as

Anti-infective therapyChemodynamic therapyNanozymePhotothermal therapyTrimetallic Pt-Pd-Au alloys

Identifiers

PMID40678265
PMCPMC12269415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.